Moderna, Inc.
Moderna, Inc.（MRNA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · MRNA · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
7
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Moderna, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
MRNA 季度内部人买卖趋势
MRNA 内幕交易卖出 · MRNA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · MRNA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
MRNA 高管卖出股份 · MRNA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 27, 2026 | Mock James M CFO | Option | 773 | — | Form 4 |
| May 28, 2026 | Mock James M CFO | Option | 328 | — | Form 4 |
| May 28, 2026 | Mock James M CFO | Other | 159 | $8K | Form 4 |
| May 27, 2026 | Mock James M CFO | Other | 374 | $18K | Form 4 |
| May 27, 2026 | Klinger Shannon Thyme Chief Legal Officer | Option | 773 | — | Form 4 |
| May 28, 2026 | Klinger Shannon Thyme Chief Legal Officer | Option | 328 | — | Form 4 |
| May 28, 2026 | Klinger Shannon Thyme Chief Legal Officer | Other | 159 | $8K | Form 4 |
| May 27, 2026 | Klinger Shannon Thyme Chief Legal Officer | Other | 374 | $18K | Form 4 |
| May 27, 2026 | Hoge Stephen President | Option | 1,437 | — | Form 4 |
| May 28, 2026 | Hoge Stephen President | Option | 610 | — | Form 4 |
| May 28, 2026 | Hoge Stephen President | Other | 295 | $14K | Form 4 |
| May 27, 2026 | Hoge Stephen President | Other | 695 | $33K | Form 4 |
| May 21, 2026 | AFEYAN NOUBAR Director | Option | 9,263 | $177K | Form 4 |
| May 21, 2026 | AFEYAN NOUBAR Director | Sale | 9,263 | $434K | Form 4 |
| May 15, 2026 | Hoge Stephen President | Option | 16,110 | $309K | Form 4 |
| May 15, 2026 | Hoge Stephen President | Option | 37,226 | $713K | Form 4 |
| May 15, 2026 | Hoge Stephen President | Sale | 53,336 | $2.58M⚡ | Form 4 |
| Apr 30, 2026 | Horning Sandra Director | Option | 16,233 | — | Form 4 |
| Apr 30, 2026 | Rubenstein David M. Director | Option | 8,116 | — | Form 4 |
| Apr 30, 2026 | Hussain Abbas Director | Option | 16,233 | — | Form 4 |
| May 1, 2026 | Hussain Abbas Director | Sale | 5,682 | $265K | Form 4 |
| Apr 30, 2026 | NABEL ELIZABETH G Director | Option | 16,233 | — | Form 4 |
| Apr 30, 2026 | Nader Francois Director | Option | 12,174 | — | Form 4 |
| Apr 30, 2026 | Tallett Elizabeth E Director | Option | 4,058 | — | Form 4 |
| Apr 2, 2026 | Mock James M CFO | Option | 1,453 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 MRNA 内幕交易
MRNA 内幕交易
Moderna, Inc.（MRNA）内幕交易数据来源于公司内部人（包括Klinger Shannon Thyme (Chief Legal Officer), Hoge Stephen (President), Mock James M (CFO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。MRNA内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Moderna, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
MRNA 内幕交易 · 5个问题Moderna, Inc.（MRNA）的内部人包括高管和董事，如Klinger Shannon Thyme (Chief Legal Officer), Hoge Stephen (President), Mock James M (CFO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026